NOXOPHARM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.06 AUD | 0.00% |
|
0.00% | -15.49% |
| Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
| Feb. 27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 11.53M | - | - | - | - | - | |
| 88.91B | ||||||
| 41.25B | ||||||
| 31.99B | ||||||
| 24.73B | ||||||
| 15.54B |
- Stock Market
- Equities
- NOX Stock
- Charts Noxopharm Limited
- Sector Chart